Drug discovery for autoimmune diseases is recently recognized to be an important task. In this study, we try to perform structure prediction of proteins whose gene promoter regions were previously reported to be specifically methelysed or demethylased commonly for three autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, and dermatomyositis. FAMS were employed for this purpose and we can predict three dimensional structure with significantly small enough P-values. Most of them are suggested to be self immunology related proteins and will be important drug target candidates. We also found some proteins which form complex with each other. The possibility of a new drug target, i.e., suppression of protein complex formation is suggested.
INTRODUCTION
Autoimmune diseases are recently recognized as serious symptom. For example, systemic lupus erythematosus (SLE), which is known to be one of systemic autoimmune diseases, most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. The cause of this disease is unknown. The lack of the knowledge about basic mechanism of the disease prevents us from generating effective drugs to cure this disease. SLE is the secondly frequent connective tissue disease, while the most frequent one is Rheumatoid Arthritis (RA), which is also known to be one of autoimmune diseases. Although there are some proposals about the cause of RA, it has not yet been fully understood. In RA, the arthritis of joints known as synovitis is inflammation of the synovial membrane that lines joints and tendon sheaths. Joints become swollen, tender and warm, and stiffness limits their movement. Another example of autoimmune disease is dermatomyositis (DM), which is also a connective-tissue disease related to polymyositis that is characterized by inflammation of the muscles and the skin. Its cause is unknown, too.
In spite of the lack of basic understanding of diseases' causes, there is a general belief; there should be a common cause of autoimmune diseases. Following this line, in accordance with the recent development of genome science, several conjectures are proposed.
For example, O'Hanlon et al recently showed that there are common pathways which contribute to multiple systematic autoimmune diseases (O'Hanlon et al., 2011b) , based upon gene expression analysis. More recently, they have confirmed their findings using proteomic analysis (O'Hanlon et al., 2011a) . However, Zhou et al (Zhou et al., 2005) found that unaffected monozygotic (MZ) twins share fibroblast gene expression with systemic sclerosis (SSc) patients (counter parts). SSc is also believed to be related to autoimmune diseases. On the other hand, Gervin et al (Gervin et al., 2012) recently found that combined analysis between gene expression and methylation enables them to detect slight difference between affected and unaffected twins. Their findings are not contradict to the study by Javierre et al (Javierre et al., 2010) who could not find any shared methylation patterns among multiple autoimmune diseases. Thus, at the moment, it is a little bit confusing what kind of aspects can be shared with multiple autoimmune diseases.
A few years ago, we reanalyzed (Taguchi, 2010) Javierre et al's data (Javierre et al., 2010) using principal component analysis (PCA) and found that some genes' methylation are commonly and significantly different from healthy controls. In this paper, we try to validate our findings using Full Automatic Modeling System (FAMS), which is protein structure prediction program that perform comparative modeling with database search and simulated annealing. Using FAMS (Umeyama and Iwadate, 2002) , we can predict functionality of genes by comparing them with the proteins whose function and structure are known. We also validate if these genes can form complex and find many candidates to form protein complex. The possibility that they can be a drug target will be discussed.
MATERIALS AND METHODS

Selection of Candidate Genes
Although details are reported previously (Taguchi, 2010) , here we briefly describe how we have selected candidate genes. Javierre et al (Javierre et al., 2010) measured promoter methylation patterns using microarray technology (Illumina GoldenGate Methylation Cancer Panel I) for SLE, RA, and DM. Their expression patterns are deposited to Gene Expression Omnibus with the accession number of GSE19033. We downloaded series matrix.txt from there, applied PCA to them and picked up gene whose promoters' methylation is significantly different from healthy controls.
Structure Prediction of Selected Genes
Selected genes' amino acid sequences are downloaded from SWISS Prot. Then their protein structures are inferred by FAMS.
Protein Complex Formation Prediction
We checked if a pair of model proteins used for structure prediction can form protein complex or not as follows. First, PDB files which contains at least one model protein as a member of protein complex are downloaded. Then, which model proteins are included into the common PDB files is investigated. Thirdly, inter-atomic distances between pairs of model proteins which belong to the same PDB file are computed. If there are at least a pair of atoms whose distances are less than 3.5Å, a pair of model proteins is listed as a candidate to form protein complex. 
RESULTS
Biological Significance Figured out by FAMS
In Table 1 , we have listed genes (i.e., reference proteins) selected by PCA (Taguchi, 2010) , together with the model proteins which are inferred to have similar structure to each of them by FAMS. First of all, FAMS has successfully listed model proteins for most of reference proteins with very small P-values. Fig. 1 shows a typical example of model proteins. It is the model protein 2OQ0 B for the reference protein AIM2. Alignment regions are 192 amino acid sequence from total length of 209 amino acid of 2OQ0 B and 191 amino acid sequence from total length 343 amino acid sequence of AIM2. Sequence similarity between two alignment regions is 44 %. P-value attributed is 4 × 10 −92 . Although this is only one example of typical relationship between model/reference proteins, generally we could get this quality of structural similarities. This means structural similarity between models and references is reliable. In addition to this, biological features attributed to the model proteins are often reasonable. Due to the limitation of the space, we cannot explain all of them one by one, we will point out some of these examples. Then, modeling yields predictions that need to be experimentally verified. TRIP6 is expected to have similar structure to CRP1, which is inferred as immune response (Latonen et al., 2010) . TM7SF3 is recognized as cytochrome c oxidase, which was reported to bind to immune gamma-globulins (Frey et al., 1978) . TIE1, PECAM1 and CSF3R are recognized as DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM), which is known to be immunoglobulin (Ig)-superfamily receptor in insect (Watson et al., 2005) . SYK is recognized as TYROSINE-PROTEIN KINASE ZAP-70 and both SYK and ZAP-70 are reported to display distinct requirements for Src family kinases in immune response receptor signal transduction (Zoller et al., 1997) . STAT5A itself is found in PDB, which is reported to play critical role for cytokine responses and normal immune function (Lin et al., 2012) . SPI1 is recognized as ETS1, which is known to be expressive in SLE and play some function in immune system (Pan et al., 2011) . S100-A2 itself is in PDB and is reported to be antibodies and inhibitors directed toward receptor for advanced glycation end products (RAGE) ligands (Heijmans et al., 2012) . RARA is structurally similar to RXR-α, which is reported to be involved in inflammatory responses (Selvaraj et al., 2010) . PI3 is as WAP, which is reported to play a role in innate immune (Bingle and Vyakarnam, 2008) . PADI4 is itself in PDB and is reported to be important in RA(Abd-Allah et al., 2012). MPL's structure is inferred to be similar to IL6RB. IL6R is reported to be a key mediator of RA (Cronstein, 2007) . LCN2, which is also called as NGAL, is in PDB. NGAL is tried to be used as a marker of inflammatory status for allowing an early diagnosis of inflammatory disease such as autoimmune disease in DS patients (Dogliotti et al., 2010) . One of HOXB2's model proteins is HNF-6, which is known to cause immunologically distinct feature (Samadani and Costa, 1996) . AIM2 is struc- Figure 4 : Protein complex formation candidates between PECAM1 (Cyan) and CSF1R (Magenta) detected in Pvalue 1e-53 and 4e-68, based upon protein structure of PDB 2ZJS. Green region are excluded from matching between model and reference proteins.
turally similar to IFI16. AIM2 and IFI16 are reported to play critucal role in immunology . CARD15 is inferred to be similar to TLR4 which play a role in cell antiviral response together with TLR3: TICAM1-specific signaling pathways (Meylan et al., 2004) . CD82 is known to be ACETYLCHOLINE RECEPTOR PROTEIN which often play a critical role in immune system (Quek et al., 2012) 1 . CSF1R is assigned to be TITAN, which is known to be involved in to immune response (Skeie et al., 1998) . SPP1 is recognized as ACID PHOSPHATASE, which is known to be related to be autoimmune prostatitis (Fong et al., 1997) . LMO2, which is also known to be RHOMBOTIN-2, is known to be related to ZFAT (a zinc-finger gene in autoimmune thyroid disease susceptibility region / an immune-related transcriptional regulator containing 18 C2H2-type zinc-finger domains and one AT-hook) (Tsunoda et al., 2010) . DHCR24 is regarded as CYTOKININ DEHYDRO-GENASE. Cytokine has, not to mention, been used to refer to the immunomodulating agents. SEPT9 is homologous to SEPTIN-2, which is reported to be upregulated in cytoskeletal and immune function-related proteome profiles (Gabr et al., 2007) . IFNGR2 is regarded as FIBRONECTIN, which play a role in immune responses in organ transplant recipients (Coito et al., 2000) . CSF3 itself is in PDB, which is known to have relationship with immune system (Sarkar et al., 2012) . GRB7 is also recognized as GRB10, which play an important role in immune system, although it is in cancer (O-Sullivan et al., 2008) . HGF is related to COAGULATION FACTOR XI, which is known to be related to immunology (Bouma et al., 1983) . LTB4R
is recognized as SUBSTANCE-P RECEPTOR, which is known to have immune response to respiratory syncytial virus infection (Tripp et al., 2002) . These are only a part of immune system related features which are attributed to each gene by FAMS. Although more examples can easily be listed, we omit the rest of them because of length limitation. Anyway, it is clear that FAMS based feature attribution works very well for genes selected by PCA (Taguchi, 2010) .
Possibility of Drug Discovery
Although it is interesting enough to find that FAMS can be used for the validation of genes selected by other bioinformatic method, it will be better if we can make use of FAMS for the drug discovery.
Ligand Binding to "Pocket"
The most popular method to find drug is to find a small molecule to bind a "pocket" of each protein. If FAMS can find or suggest such a candidate for each of genes in Table 1 , it will be very useful.
For example, there are two proteins, MMP8 and MMP14, in Table 1 . They are known to coregulate target genes (Silva et al., 2012) . Both of them are recognized as members of matrix metalloproteinase (MMP) family, which is inflammation related protein family. For MMP8, using 1XUC A, which is MMP-13, as a template, FAMS successfully showed that there are many ligands likely to bind MMP8 (Fig.  2) . Similarly, for MMP14, using 1BQO B, which is MMP-3, as a template, FAMS successfully showed that there are many ligands likely to bind MMP14, too (Fig. 3) . Although it is not a finding of a new drug, this shows the potential for proteins listed in Table 1 which can be new drug targets. Further researches following this line will be waited.
Termination of Protein Complex Formation
Other and new possibility of drug target is interruption in protein complex formation. Many proteins cannot work as a single substance but can work only with forming protein complex with other proteins. Thus, if we interrupt the protein complex formation, we can also interrupt the function of protein complex.
In Table 2 In addition to these known and expected protein complex formation, there are many new findings of protein complex formation candidates. Fig. 4 shows one of such possible candidates. In Table 2 , there are 410 possible candidate pairs between CSF1R and PECAM1. Among these, there is one pair having 61 atom pairs contacting with each other. This means, there is a structure on PDB (2ZJS) which includes monomers whose protein structures are expected to be similar to CSF1R and PECAM1, respectively. 2ZJS is SecYE translocon, which are expected to function as a protein-conducting channel (Tsukazaki et al., 2008) . Although this protein complex was found in Thermus thermophilus, since this kind of proteins are expected to be highly conserved, it is highly possible that CSF1R and PECAM1 form protein complex which is secreted across or integrated into membranes and play critical role in autoimmune diseases. Thus if we can find the drug which terminates the protein complex formation between CSF1R and PECAM1, it may cure autoimmune diseases.
Predicted protein-protein complex candidates detected are reported in Table 2 , but detailed discussion is deferred due to space constrains. This will be reported in some other opportunity.
CONCLUSIONS
In this study, we have demonstrated that how well FAMS can predict protein structures of candidate genes which may play critical roles in autoimmune diseases. Based upon inferred structure, we could annotate protein functions, could infer possible ligand pockets which can bind to proteins, and could find possible pairs of proteins which can form proten complex, which can be possible candidates of the drug target. It is confirmed that FAMS can work with other bioinformatic programs.
